TGFBR1 and neoplasm: Although the exact mechanism by which endoglin induces tumor angiogenesis remains to be illustrated, it is well accepted that endoglin acts as a positive regulator of ALK1 signaling and a negative regulator of ALK5 signaling in endothelial cells [42]–[43].